AMARIN CORP PLC\UK
AMRN · XNASCIK 897448fmd_14VN3J6MV2V3RX78J24V8Q3Z7JManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 68 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 130 | 181 | 229 | 430 | 614 | 583 | 369 | 307 | 229 | 214 |
| Rental revenue | – | – | – | – | – | – | – | 1 | 1 | 1 |
| Cost of revenue | 34 | 45 | 55 | 96 | 131 | 121 | – | – | – | – |
| Gross profit | 96 | 136 | 175 | 334 | 483 | 462 | 242 | 166 | 81 | 121 |
| Research and development | 50 | 47 | 56 | 34 | 39 | 29 | 30 | 22 | 21 | 20 |
| Gain on sale of real estate | – | – | – | – | – | – | – | – | – | – |
| Selling, general and administrative | 111 | 135 | 227 | 324 | 463 | 408 | 304 | 200 | 152 | 115 |
| Total operating expenses | 161 | 182 | 283 | 358 | 502 | 451 | 348 | 233 | 173 | 171 |
| Operating income | (66) | (46) | (108) | (24) | (20) | 11 | (106) | (68) | (92) | (50) |
| Interest expense | 19 | 10 | 9 | 7 | 3 | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 1 | 8 | 5 | 1 | 3 | 12 | 13 | 11 |
| Other non-operating income (expense) | (0) | 0 | (0) | (0) | 0 | (0) | (1) | 2 | 1 | 3 |
| Income before taxes | (76) | (55) | (116) | (22) | (17) | 11 | (104) | (54) | (77) | (36) |
| Income tax expense | 10 | 13 | 0 | 0 | 1 | 4 | 2 | 5 | 5 | 3 |
| Net income from continuing operations | (86) | (68) | (116) | (23) | (18) | 8 | (106) | (59) | (82) | (39) |
| Net income | (86) | (68) | (116) | (23) | (18) | 8 | (106) | (59) | (82) | (39) |
| Net income to common shareholders | (86) | (68) | – | – | – | 8 | (106) | (59) | (82) | (39) |